Company Overview

Novitious, a dynamic pharmaceutical company established in 2023, is at the forefront of providing cutting-edge Clinical Nutrition & Infusion products to improve the well-being of individuals. Novitious itself means something that is “newly invented’’.

pharmaceutical company

Committed to a vision of contributing to the lives of patients and healthcare professionals, Novitious stands firmly on the 5 pillars of Accessibility, Affordability, Acceptance, Agility, and Adaptability. With a strong belief in the power of innovation, Novitious continuously strives to develop groundbreaking solutions that address the ever-evolving healthcare challenges.

By prioritizing accessibility and affordability, we ensure that our quality products reach those in need, regardless of geographical or socioeconomic barriers. At Novitious, we foster a culture of acceptance, valuing diversity and inclusivity in our pursuit of advancing knowledge. Guided by agility and adaptability, we remain responsive to the changing landscape, enabling rapid response to emerging clinical needs.

Our unwavering commitment to quality, transparency, and patient-centricity sets us apart, driving us to create a healthier and more vibrant world.c

core

Business model:

Novitious Pharma primarily market products across multiple markets and therapeutic segments, Deal in Clinical Nutrition (including Enteral Nutrition & Parenteral Nutrition), Infusion products across therapeutic segments (including Specialized IV FluidAnalgesia and Plasma Volume Expanders).

We offer injectables via various delivery systems, such as glass and plastic bottles (EURO Head) and non-PVC/PVC bags.

Customer base primarily includes Private Corporate Hospitals, Government Hospitals and Nursing homes. 

Financial feasibility:

Our commitment to financial feasibility ensures sustainable growth and long-term success.

Ensuring economic viability while generating sustainable revenue to support our research and development efforts.

Strategic Product Segment to focus: